This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bamforth, S. D. Articles by Greenwood, J. Search for Related Content PubMed PubMed Citation Articles by Bamforth, S. D. Articles by Greenwood, J.

American Journal of Pathology, Vol 150, 329-340, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine

SD Bamforth, SL Lightman and J Greenwood
Department of Clinical Ophthalmology, University College London, United Kingdom.

The vascular barriers of the central nervous system form a selective cellular interface between the blood and the neural parenchyma and restrict the transfer of both molecules and hematogenous cells. During immune-mediated diseases, leukocyte infiltration becomes dramatically up-regulated and the permeability of these barriers increases, leading to edema formation. The etiology of this damage remains largely unresolved although inflammatory cytokines have been implicated in the process. The effect of the proinflammatory cytokine interleukin (IL)-1 beta on the integrity of the rat blood-retinal barrier (BRB) was investigated up to 14 days after an intravitreal injection. The permeability of the BRB was evaluated quantitatively using the low molecular weight tracer [14C]mannitol. After IL-1 beta administration, a biphasic opening of the BRB to [14C]mannitol was recorded, peaking at 4 to 8 hours and 24 to 48 hours post-injection (PI). The early disruption coincided with the appearance of both polymorphonuclear and mononuclear leukocytes within the retina. By 12 hours PI, BRB permeability had returned to control values despite a continued increase in the number of infiltrating leukocytes. The second, more pronounced increase in barrier permeability detected at 24 to 48 hours PI corresponded with maximal leukocyte infiltration. Barrier dysfunction had resolved by 72 hours, and by 7 days the leukocyte infiltrate had disappeared. The IL-1 beta-induced increase in permeability could be completely abrogated at 4 and 24 hours PI by treating the animals with the histamine H2-receptor antagonist ranitidine, which also reduced leukocyte infiltration by 47.2%. The ability of histamine to disrupt the BRB was demonstrated by intravitreal and intravascular administration, which caused a rapid and significant increase in BRB permeability. Treatment of the animals with the cyclo-oxygenase inhibitor indomethacin had no effect on IL-1 beta- induced disruption of the BRB at 4 hours PI, but by 24 hours PI a significant reduction in permeability was observed that coincided with a 75.2% reduction in the leukocyte infiltrate. The depletion of circulating leukocytes to < 2% of control levels reduced the retinal leukocyte recruitment induced by IL-1 beta by 73.0% and decreased BRB permeability at both 4 and 24 hours after IL-1 beta injection. These data demonstrate that intravitreal IL-1 beta in the rat induces a biphasic opening of the BRB that appears to be mediated through recruited leukocytes and release of the vasoactive amine histamine.

This article has been cited by other articles:

				H. Xu, R. Dawson, I. J. Crane, and J. Liversidge Leukocyte Diapedesis In Vivo Induces Transient Loss of Tight Junction Protein at the Blood-Retina Barrier Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2487 - 2494. [Abstract] [Full Text] [PDF]

				C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 349 - 357. [Abstract] [Full Text] [PDF]

				T. Abe, E. Sugano, Y. Saigo, and M. Tamai Interleukin-1{beta} and Barrier Function of Retinal Pigment Epithelial Cells (ARPE-19): Aberrant Expression of Junctional Complex Molecules Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4097 - 4104. [Abstract] [Full Text] [PDF]

				H. Xu, J. V. Forrester, J. Liversidge, and I. J. Crane Leukocyte Trafficking in Experimental Autoimmune Uveitis: Breakdown of Blood-Retinal Barrier and Upregulation of Cellular Adhesion Molecules Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 226 - 234. [Abstract] [Full Text] [PDF]

				N. L. Derevjanik, S. A. Vinores, W.-H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, and P. A. Campochiaro Quantitative Assessment of the Integrity of the Blood-Retinal Barrier in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2462 - 2467. [Abstract] [Full Text] [PDF]

				A. Nonaka, J. Kiryu, A. Tsujikawa, K. Yamashiro, K. Nishijima, H. Kamizuru, Y. Ieki, K. Miyamoto, H. Nishiwaki, Y. Honda, et al. Inflammatory Response after Scatter Laser Photocoagulation in Nonphotocoagulated Retina Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1204 - 1209. [Abstract] [Full Text] [PDF]

				M. J. Gastinger, A. J. Barber, S. A. Khin, C. S. McRill, T. W. Gardner, and D. W. Marshak Abnormal Centrifugal Axons in Streptozotocin- Diabetic Rat Retinas Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2679 - 2685. [Abstract] [Full Text] [PDF]

				D. KENT, S. A VINORES, and P. A CAMPOCHIARO Macular oedema: the role of soluble mediators Br. J. Ophthalmol., May 1, 2000; 84(5): 542 - 545. [Full Text]

				M. J. Giese, D. C. Shum, S. A. Rayner, B. J. Mondino, and J. A. Berliner Adhesion Molecule Expression in a Rat Model of Staphylococcus aureus Endophthalmitis Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 145 - 153. [Abstract] [Full Text]

				M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto Differences in Cellular Responses to Mitogens in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease Stroke, June 1, 1998; 29(6): 1188 - 1193. [Abstract] [Full Text] [PDF]